Schedule 13G ownership disclosure

CANCER GENETICS INC.

Security class unavailable · CUSIP: 13739U104

Event date: 2019-01-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,500,000
Percent of class
3.6500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000051
Form type
SC 13G
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Jan 10, 2019
Reporting period
Jan 10, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub